nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—SLC2A1—hindbrain—Parkinson's disease	0.0289	0.0915	CbGeAlD
Etomidate—SLC2A1—embryo—Parkinson's disease	0.0181	0.0572	CbGeAlD
Etomidate—SLC2A1—brainstem—Parkinson's disease	0.0166	0.0524	CbGeAlD
Etomidate—SLC2A1—forebrain—Parkinson's disease	0.016	0.0506	CbGeAlD
Etomidate—SLC2A1—cardiovascular system—Parkinson's disease	0.0135	0.0428	CbGeAlD
Etomidate—CYP11B2—cardiovascular system—Parkinson's disease	0.0116	0.0367	CbGeAlD
Etomidate—GABRB2—hindbrain—Parkinson's disease	0.0113	0.0357	CbGeAlD
Etomidate—SLC2A1—midbrain—Parkinson's disease	0.0106	0.0334	CbGeAlD
Etomidate—SLC2A1—spinal cord—Parkinson's disease	0.0103	0.0326	CbGeAlD
Etomidate—GABRA1—hindbrain—Parkinson's disease	0.00995	0.0315	CbGeAlD
Etomidate—SLC2A1—head—Parkinson's disease	0.00915	0.029	CbGeAlD
Etomidate—SLC2A1—nervous system—Parkinson's disease	0.00867	0.0275	CbGeAlD
Etomidate—SLC2A1—central nervous system—Parkinson's disease	0.00835	0.0265	CbGeAlD
Etomidate—SLC2A1—cerebellum—Parkinson's disease	0.00816	0.0259	CbGeAlD
Etomidate—Ephedrine—SLC18A2—Parkinson's disease	0.00779	0.249	CrCbGaD
Etomidate—SLC2A1—brain—Parkinson's disease	0.00663	0.021	CbGeAlD
Etomidate—GABRB2—brainstem—Parkinson's disease	0.00646	0.0205	CbGeAlD
Etomidate—GABRB2—forebrain—Parkinson's disease	0.00623	0.0197	CbGeAlD
Etomidate—GABRG2—forebrain—Parkinson's disease	0.00623	0.0197	CbGeAlD
Etomidate—GABRA1—brainstem—Parkinson's disease	0.0057	0.0181	CbGeAlD
Etomidate—GABRA1—forebrain—Parkinson's disease	0.0055	0.0174	CbGeAlD
Etomidate—Diethylpropion—SLC6A3—Parkinson's disease	0.00545	0.174	CrCbGaD
Etomidate—Pethidine—GRIN2B—Parkinson's disease	0.00537	0.171	CrCbGaD
Etomidate—CYP19A1—forebrain—Parkinson's disease	0.00505	0.016	CbGeAlD
Etomidate—GABRG2—medulla oblongata—Parkinson's disease	0.0045	0.0143	CbGeAlD
Etomidate—GABRB2—medulla oblongata—Parkinson's disease	0.0045	0.0143	CbGeAlD
Etomidate—GABRB2—midbrain—Parkinson's disease	0.00411	0.013	CbGeAlD
Etomidate—GABRG2—midbrain—Parkinson's disease	0.00411	0.013	CbGeAlD
Etomidate—GABRG2—spinal cord—Parkinson's disease	0.00401	0.0127	CbGeAlD
Etomidate—GABRB2—spinal cord—Parkinson's disease	0.00401	0.0127	CbGeAlD
Etomidate—GABRA1—medulla oblongata—Parkinson's disease	0.00398	0.0126	CbGeAlD
Etomidate—GABRA1—midbrain—Parkinson's disease	0.00363	0.0115	CbGeAlD
Etomidate—GABRG2—head—Parkinson's disease	0.00357	0.0113	CbGeAlD
Etomidate—GABRB2—head—Parkinson's disease	0.00357	0.0113	CbGeAlD
Etomidate—GABRA1—spinal cord—Parkinson's disease	0.00354	0.0112	CbGeAlD
Etomidate—GABRG2—nervous system—Parkinson's disease	0.00338	0.0107	CbGeAlD
Etomidate—GABRB2—nervous system—Parkinson's disease	0.00338	0.0107	CbGeAlD
Etomidate—GABRB2—central nervous system—Parkinson's disease	0.00326	0.0103	CbGeAlD
Etomidate—GABRG2—central nervous system—Parkinson's disease	0.00326	0.0103	CbGeAlD
Etomidate—GABRB2—cerebellum—Parkinson's disease	0.00318	0.0101	CbGeAlD
Etomidate—GABRG2—cerebellum—Parkinson's disease	0.00318	0.0101	CbGeAlD
Etomidate—GABRA1—head—Parkinson's disease	0.00315	0.00998	CbGeAlD
Etomidate—GABRA1—nervous system—Parkinson's disease	0.00299	0.00946	CbGeAlD
Etomidate—CYP19A1—head—Parkinson's disease	0.00289	0.00916	CbGeAlD
Etomidate—GABRA1—central nervous system—Parkinson's disease	0.00288	0.00911	CbGeAlD
Etomidate—Pseudoephedrine—MAOA—Parkinson's disease	0.00284	0.0906	CrCbGaD
Etomidate—GABRA1—cerebellum—Parkinson's disease	0.00281	0.00891	CbGeAlD
Etomidate—CYP19A1—nervous system—Parkinson's disease	0.00274	0.00869	CbGeAlD
Etomidate—CYP19A1—central nervous system—Parkinson's disease	0.00264	0.00837	CbGeAlD
Etomidate—GABRG2—brain—Parkinson's disease	0.00259	0.00819	CbGeAlD
Etomidate—GABRB2—brain—Parkinson's disease	0.00259	0.00819	CbGeAlD
Etomidate—Pethidine—SLC6A3—Parkinson's disease	0.00254	0.0809	CrCbGaD
Etomidate—Pseudoephedrine—SLC6A3—Parkinson's disease	0.00245	0.0782	CrCbGaD
Etomidate—GABRA1—brain—Parkinson's disease	0.00228	0.00723	CbGeAlD
Etomidate—Pseudoephedrine—TNF—Parkinson's disease	0.00228	0.0726	CrCbGaD
Etomidate—CYP19A1—brain—Parkinson's disease	0.0021	0.00664	CbGeAlD
Etomidate—Pethidine—CYP2D6—Parkinson's disease	0.00133	0.0425	CrCbGaD
Etomidate—Pseudoephedrine—CYP2D6—Parkinson's disease	0.00129	0.0411	CrCbGaD
Etomidate—ADRA2B—GPCR ligand binding—PENK—Parkinson's disease	0.000507	0.000776	CbGpPWpGaD
Etomidate—CYP19A1—Biological oxidations—GSTM1—Parkinson's disease	0.0005	0.000765	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—CHRNA4—Parkinson's disease	0.000497	0.000762	CbGpPWpGaD
Etomidate—CYP19A1—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000493	0.000755	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—DRD3—Parkinson's disease	0.000491	0.000752	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—DLG4—Parkinson's disease	0.000489	0.00075	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.000487	0.000746	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CYP2D6—Parkinson's disease	0.000483	0.000739	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.000481	0.000737	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00048	0.000734	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—GRIN2B—Parkinson's disease	0.000478	0.000733	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000474	0.000726	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CTGF—Parkinson's disease	0.000474	0.000726	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—DBH—Parkinson's disease	0.000474	0.000726	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GBA—Parkinson's disease	0.000474	0.000726	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—FBP1—Parkinson's disease	0.000474	0.000726	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—SLC6A3—Parkinson's disease	0.000471	0.000722	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.000471	0.000721	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—PDYN—Parkinson's disease	0.000463	0.00071	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000457	0.0007	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—HSPA8—Parkinson's disease	0.000456	0.000698	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.000456	0.000698	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000454	0.000695	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—MAG—Parkinson's disease	0.000453	0.000694	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000452	0.000692	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—DGKQ—Parkinson's disease	0.000444	0.000681	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—DRD2—Parkinson's disease	0.000444	0.00068	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CYP2E1—Parkinson's disease	0.000442	0.000676	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—COMT—Parkinson's disease	0.000438	0.000671	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—NQO1—Parkinson's disease	0.000437	0.000669	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—MAOA—Parkinson's disease	0.000435	0.000667	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—GRM5—Parkinson's disease	0.000431	0.00066	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—TH—Parkinson's disease	0.00043	0.000659	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—DLG4—Parkinson's disease	0.000428	0.000655	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000423	0.000647	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—GRIN2B—Parkinson's disease	0.000418	0.00064	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.000417	0.000639	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CYCS—Parkinson's disease	0.000413	0.000633	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000412	0.000631	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000412	0.000631	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—SLC6A3—Parkinson's disease	0.000412	0.000631	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—SOD1—Parkinson's disease	0.000412	0.00063	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000411	0.00063	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—DDC—Parkinson's disease	0.000404	0.000618	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GPR37—Parkinson's disease	0.000404	0.000618	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—DGKQ—Parkinson's disease	0.000404	0.000618	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000403	0.000617	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—COMT—Parkinson's disease	0.000401	0.000614	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—MAOA—Parkinson's disease	0.000398	0.00061	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—IGF2—Parkinson's disease	0.000391	0.000599	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00039	0.000598	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000389	0.000596	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000387	0.000592	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTA4—Parkinson's disease	0.000381	0.000584	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000376	0.000576	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000376	0.000576	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—HGF—Parkinson's disease	0.000369	0.000565	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000369	0.000565	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000366	0.000561	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—COMT—Parkinson's disease	0.000366	0.00056	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—GSTP1—Parkinson's disease	0.000364	0.000558	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—MAOA—Parkinson's disease	0.000363	0.000556	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—HMOX1—Parkinson's disease	0.000359	0.00055	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000356	0.000545	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—MCCC1—Parkinson's disease	0.000354	0.000543	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ND3—Parkinson's disease	0.000354	0.000543	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000353	0.000541	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000353	0.000541	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MTHFR—Parkinson's disease	0.000353	0.000541	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—COMT—Parkinson's disease	0.00035	0.000537	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—MAOA—Parkinson's disease	0.000348	0.000533	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—DDC—Parkinson's disease	0.000348	0.000533	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—ABCB1—Parkinson's disease	0.000345	0.000528	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PLA2G6—Parkinson's disease	0.000343	0.000525	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—MAOB—Parkinson's disease	0.00034	0.00052	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000338	0.000517	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GRK5—Parkinson's disease	0.000337	0.000516	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—GSTM1—Parkinson's disease	0.000335	0.000512	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—TALDO1—Parkinson's disease	0.000333	0.00051	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—OMD—Parkinson's disease	0.000333	0.00051	CbGpPWpGaD
Etomidate—SLC2A1—Disease—APOE—Parkinson's disease	0.000329	0.000503	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTA4—Parkinson's disease	0.000328	0.000503	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000324	0.000497	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000323	0.000495	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—GPX1—Parkinson's disease	0.00032	0.000491	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—HTR1A—Parkinson's disease	0.000318	0.000487	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—NDUFB11—Parkinson's disease	0.000316	0.000484	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—TAC1—Parkinson's disease	0.000313	0.000479	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000311	0.000476	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—DRD1—Parkinson's disease	0.000307	0.00047	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GRK5—Parkinson's disease	0.000306	0.000468	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GRM4—Parkinson's disease	0.000302	0.000463	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GCH1—Parkinson's disease	0.000301	0.000461	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—DRD3—Parkinson's disease	0.000297	0.000455	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—MTHFR—Parkinson's disease	0.000296	0.000453	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PLA2G6—Parkinson's disease	0.000296	0.000453	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—MAOB—Parkinson's disease	0.000293	0.000448	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—Parkinson's disease	0.00029	0.000444	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000289	0.000442	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VPS35—Parkinson's disease	0.000288	0.000441	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PENK—Parkinson's disease	0.000286	0.000439	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—FGB—Parkinson's disease	0.000286	0.000438	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000283	0.000433	CbGpPWpGaD
Etomidate—SLC2A1—Disease—INS—Parkinson's disease	0.000281	0.00043	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000279	0.000427	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000277	0.000424	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—APOE—Parkinson's disease	0.000275	0.000422	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GRM4—Parkinson's disease	0.000274	0.00042	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000272	0.000416	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—HTR7—Parkinson's disease	0.000269	0.000412	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—DRD2—Parkinson's disease	0.000269	0.000412	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GBA—Parkinson's disease	0.000269	0.000411	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—FBP1—Parkinson's disease	0.000269	0.000411	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—DBH—Parkinson's disease	0.000269	0.000411	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000268	0.00041	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000267	0.000409	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000266	0.000408	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PDYN—Parkinson's disease	0.000262	0.000401	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PENK—Parkinson's disease	0.00026	0.000398	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000254	0.000388	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CYP2D6—Parkinson's disease	0.000252	0.000387	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CTGF—Parkinson's disease	0.000248	0.000379	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000247	0.000379	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GRM5—Parkinson's disease	0.000244	0.000373	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000243	0.000373	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—DGKQ—Parkinson's disease	0.000238	0.000365	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GPR37—Parkinson's disease	0.000238	0.000365	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PDYN—Parkinson's disease	0.000238	0.000364	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—INS—Parkinson's disease	0.000235	0.00036	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000231	0.000354	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CYP2E1—Parkinson's disease	0.000231	0.000354	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—NQO1—Parkinson's disease	0.000228	0.00035	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—TH—Parkinson's disease	0.000225	0.000345	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000222	0.00034	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000222	0.000339	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GRM5—Parkinson's disease	0.000221	0.000339	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000218	0.000334	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CYP2D6—Parkinson's disease	0.000218	0.000333	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CYCS—Parkinson's disease	0.000216	0.000331	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—EDN1—Parkinson's disease	0.000215	0.00033	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CTGF—Parkinson's disease	0.000214	0.000327	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000213	0.000326	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SOD1—Parkinson's disease	0.000212	0.000325	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000212	0.000324	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000207	0.000317	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000203	0.000311	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—ABL1—Parkinson's disease	0.000202	0.00031	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IGF2—Parkinson's disease	0.000202	0.000309	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CYP2E1—Parkinson's disease	0.000199	0.000305	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—DDC—Parkinson's disease	0.000197	0.000302	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—NQO1—Parkinson's disease	0.000197	0.000301	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000194	0.000297	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—TH—Parkinson's disease	0.000194	0.000297	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—COMT—Parkinson's disease	0.000191	0.000293	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RIT2—Parkinson's disease	0.000191	0.000292	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTP1—Parkinson's disease	0.00019	0.000292	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—HGF—Parkinson's disease	0.00019	0.000291	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—MAOA—Parkinson's disease	0.00019	0.000291	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—HTR2A—Parkinson's disease	0.000188	0.000288	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000188	0.000288	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—HMOX1—Parkinson's disease	0.000188	0.000288	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CYCS—Parkinson's disease	0.000186	0.000285	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTA4—Parkinson's disease	0.000186	0.000285	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000185	0.000283	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000184	0.000281	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GRK5—Parkinson's disease	0.000181	0.000277	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ABCB1—Parkinson's disease	0.00018	0.000276	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00018	0.000275	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000178	0.000272	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—TAC1—Parkinson's disease	0.000177	0.000271	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTM1—Parkinson's disease	0.000175	0.000268	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—DRD1—Parkinson's disease	0.000174	0.000266	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—DRD3—Parkinson's disease	0.000168	0.000257	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PLA2G6—Parkinson's disease	0.000168	0.000257	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GPX1—Parkinson's disease	0.000168	0.000257	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—MAOB—Parkinson's disease	0.000166	0.000254	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—COMT—Parkinson's disease	0.000165	0.000252	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTP1—Parkinson's disease	0.000164	0.000251	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—MAOA—Parkinson's disease	0.000164	0.000251	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR1A—Parkinson's disease	0.000163	0.00025	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GRM4—Parkinson's disease	0.000162	0.000248	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—HMOX1—Parkinson's disease	0.000162	0.000248	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—TAC1—Parkinson's disease	0.000161	0.000246	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000158	0.000242	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—DRD1—Parkinson's disease	0.000158	0.000241	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000157	0.00024	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000157	0.00024	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ABCB1—Parkinson's disease	0.000155	0.000238	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—MTHFR—Parkinson's disease	0.000155	0.000237	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PENK—Parkinson's disease	0.000154	0.000235	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MAG—Parkinson's disease	0.000154	0.000235	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—DRD3—Parkinson's disease	0.000153	0.000234	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—DRD2—Parkinson's disease	0.000152	0.000233	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—HTR7—Parkinson's disease	0.000152	0.000233	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTM1—Parkinson's disease	0.000151	0.000231	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GPX1—Parkinson's disease	0.000144	0.000221	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—APOE—Parkinson's disease	0.000144	0.00022	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000142	0.000218	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PDYN—Parkinson's disease	0.000141	0.000215	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—DRD2—Parkinson's disease	0.000138	0.000211	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR7—Parkinson's disease	0.000138	0.000211	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—MTHFR—Parkinson's disease	0.000133	0.000204	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GFAP—Parkinson's disease	0.000132	0.000202	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GRM5—Parkinson's disease	0.000131	0.0002	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—APOE—Parkinson's disease	0.000124	0.00019	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP2D6—Parkinson's disease	0.000123	0.000189	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—INS—Parkinson's disease	0.000123	0.000188	CbGpPWpGaD
Etomidate—SLC2A1—Disease—IL6—Parkinson's disease	0.000123	0.000188	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—EDN1—Parkinson's disease	0.000122	0.000186	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CTGF—Parkinson's disease	0.000121	0.000185	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FGF20—Parkinson's disease	0.000115	0.000175	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP2E1—Parkinson's disease	0.000113	0.000173	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—NQO1—Parkinson's disease	0.000112	0.000171	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ADORA2A—Parkinson's disease	0.000111	0.00017	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—EDN1—Parkinson's disease	0.00011	0.000169	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—TH—Parkinson's disease	0.00011	0.000168	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000106	0.000163	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—INS—Parkinson's disease	0.000106	0.000162	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYCS—Parkinson's disease	0.000106	0.000162	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—INSR—Parkinson's disease	0.000103	0.000157	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FGB—Parkinson's disease	9.69e-05	0.000148	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR2A—Parkinson's disease	9.67e-05	0.000148	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR1A—Parkinson's disease	9.64e-05	0.000148	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TAC1—Parkinson's disease	9.49e-05	0.000145	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—COMT—Parkinson's disease	9.34e-05	0.000143	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—DRD1—Parkinson's disease	9.31e-05	0.000143	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTP1—Parkinson's disease	9.3e-05	0.000142	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—MAOA—Parkinson's disease	9.28e-05	0.000142	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—HMOX1—Parkinson's disease	9.17e-05	0.00014	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—DRD3—Parkinson's disease	9.01e-05	0.000138	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ABCB1—Parkinson's disease	8.8e-05	0.000135	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTM1—Parkinson's disease	8.55e-05	0.000131	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ADRBK1—Parkinson's disease	8.42e-05	0.000129	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GPX1—Parkinson's disease	8.18e-05	0.000125	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR7—Parkinson's disease	8.15e-05	0.000125	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—DRD2—Parkinson's disease	8.15e-05	0.000125	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—MTHFR—Parkinson's disease	7.55e-05	0.000116	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—APOE—Parkinson's disease	7.03e-05	0.000108	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IGF2—Parkinson's disease	6.83e-05	0.000105	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IGF1R—Parkinson's disease	6.61e-05	0.000101	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EDN1—Parkinson's disease	6.53e-05	9.99e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—INS—Parkinson's disease	6.01e-05	9.2e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NGF—Parkinson's disease	6e-05	9.18e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR2A—Parkinson's disease	5.71e-05	8.74e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APOE—Parkinson's disease	5.31e-05	8.13e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—INS—Parkinson's disease	4.53e-05	6.94e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CASP3—Parkinson's disease	3.38e-05	5.17e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL6—Parkinson's disease	3.35e-05	5.14e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MAPK8—Parkinson's disease	3.1e-05	4.75e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL6—Parkinson's disease	1.98e-05	3.03e-05	CbGpPWpGaD
